酶吸收促进剂用于非侵入性递送
Marilena Bohley Steiger1, Angela Steinauer2, Daniel Gao1
1Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich, Switzerland.
概括
酶可以通过非侵入性途径增强类药物吸收. 这项研究表明,酶可以改善口服和口腔输送的类药物,如德斯莫普林素和半胺,克服生物障碍.
科学领域:
- 生物技术是生物技术.
- 药物运输 药物运输 药物运输
- 药理学 药理学是指药理学的学科.
背景情况:
- 类药物是有效的治疗药物,但由于吸收不良,仅限于注射.
- 粘液和上皮细胞等生物障碍阻碍了非侵入性类药物递送 (口服,口腔).
研究的目的:
- 为了研究增强非侵入性类药物吸收的酶策略.
- 通过酶屏障调节来证明类药物的改善生物可用性和输送.
主要方法:
- 采用粘酶来增加粘液扩散性和脂酶来提高上皮质透性.
- 在狗模型中测试了肠道囊与德斯莫普林素和酶.
- 与口服配方相比,评估了用semaglutide和phospholipase的口腔贴片.
主要成果:
- 带有酶的肠道德斯莫普雷辛囊显示155%的相对生物利用率与单独使用药物相比.
- 布卡尔塞马格卢提德贴片与脂酶实现了5倍更高的生物可用性.
- 口分娩显示,semaglutide的变化系数减少了71.5%.
结论:
- 生物障碍物的酶调节是改善非侵入性类药物递送的可行策略.
- 这种方法增强了吸收,并减少了口服和口腔配方的可变性.
- 在非侵入性输送和宏分子药物的更广泛应用的潜力.
相关概念视频
Carrier-Mediated Transport
223
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
223
Drug Absorption: Overview
465
The process of drug absorption signifies the transition of a drug from its site of administration into the plasma. This process is influenced by various factors, including the route of administration, the anatomy of the absorption site, the mechanism of absorption, gut motility, and the drug's physicochemical properties.
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
465
Protein Digestion
101.1K
Protein digestion begins in the stomach, where the highly acidic environment can easily disrupt protein structure by exposing the peptide bonds of polypeptide chains. After polypeptide chains are broken into individual amino acids by a series of digestive enzymes, the amino acids are transported to the liver via the bloodstream to produce energy.
101.1K
Prodrugs
2.3K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.3K
Factors Influencing Drug Absorption: Physicochemical Parameters
189
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
189
Drug Delivery: Enteral Route
350
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
350


